# Expanded Access for Anti-IL8

> **NCT05210894** · — · NO_LONGER_AVAILABLE · sponsor: **Bristol-Myers Squibb**

## Conditions studied

_None listed._

## Interventions

- **BIOLOGICAL:** Anti-IL8

## Key facts

- **NCT ID:** NCT05210894
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2022-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05210894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05210894, "Expanded Access for Anti-IL8". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05210894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*